Skip to main content
. Author manuscript; available in PMC: 2019 Jan 18.
Published in final edited form as: ACS Appl Mater Interfaces. 2018 May 15;10(21):17792–17808. doi: 10.1021/acsami.8b05607

Figure 3.

Figure 3.

Cell viability (by MTT assay) of HT-29 cancer cells treated with Au NPs bearing different surface ligands, at three different concentrations, under a) normoxic and b) hypoxic conditions. Au NPs-LA-PEG2000-CAI (100 µM) were able to kill cancer cells under hypoxic conditions in a statistically-significant manner (P < 0.05).